-
Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027
Despite constraints due to the COVID-19 pandemic, the Paris-based IRDiRC continues efforts for 1,000 new therapies and better rare disease care by 2027. Read more here.
Do you think this goal is attainable? Why or why not?
-
1 Reply
-
Just my personal opinion but I think we are on the cusp of major breakthroughs in genetic science. Whether it’s our knowledge of gene therapy and how to achieve it, or technologies like CRSPR, we will see some big things ahead.
Log in to reply.